ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 80 filers reported holding ENZON PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $11,000 | -26.7% | 21,300 | 0.0% | 0.00% | – |
| Q4 2015 | $15,000 | -28.6% | 21,300 | 0.0% | 0.00% | – |
| Q3 2015 | $21,000 | -19.2% | 21,300 | 0.0% | 0.00% | – |
| Q2 2015 | $26,000 | +13.0% | 21,300 | 0.0% | 0.00% | – |
| Q1 2015 | $23,000 | -4.2% | 21,300 | 0.0% | 0.00% | – |
| Q4 2014 | $24,000 | 0.0% | 21,300 | 0.0% | 0.00% | – |
| Q3 2014 | $24,000 | +4.3% | 21,300 | 0.0% | 0.00% | – |
| Q2 2014 | $23,000 | -72.0% | 21,300 | -73.1% | 0.00% | – |
| Q1 2014 | $82,000 | -10.9% | 79,300 | 0.0% | 0.00% | – |
| Q4 2013 | $92,000 | -83.5% | 79,300 | -75.1% | 0.00% | -100.0% |
| Q3 2013 | $557,000 | -28.5% | 318,220 | -22.3% | 0.00% | -50.0% |
| Q2 2013 | $779,000 | – | 409,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 4,337,858 | $5,032,000 | 0.14% |
| PRICE MICHAEL F | 748,200 | $868,000 | 0.11% |
| ALGERT GLOBAL LLC | 124,891 | $145,000 | 0.04% |
| Rotella Capital Management, Inc. | 13,701 | $16,000 | 0.03% |
| Icahn Capital | 5,904,863 | $6,850,000 | 0.02% |
| Spark Investment Management LLC | 110,100 | $127,000 | 0.02% |
| FCG ADVISORS, LLC | 20,000 | $23,000 | 0.02% |
| BRANDES INVESTMENT PARTNERS, LP | 1,023,893 | $1,188,000 | 0.02% |
| GLOBEFLEX CAPITAL L P | 101,454 | $117,000 | 0.01% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 129,089 | $149,000 | 0.01% |